BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22030403)

  • 1. Fertility-sparing treatment in younger women with adenocarcinoma in situ of the cervix.
    van Hanegem N; Barroilhet LM; Nucci MR; Bernstein M; Feldman S
    Gynecol Oncol; 2012 Jan; 124(1):72-7. PubMed ID: 22030403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility-sparing surgery in 101 women with adenocarcinoma in situ of the cervix.
    Bull-Phelps SL; Garner EI; Walsh CS; Gehrig PA; Miller DS; Schorge JO
    Gynecol Oncol; 2007 Nov; 107(2):316-9. PubMed ID: 17689593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conservative management of adenocarcinoma in situ of the cervix.
    Shin CH; Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Oct; 79(1):6-10. PubMed ID: 11006022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
    Poynor EA; Barakat RR; Hoskins WJ
    Gynecol Oncol; 1995 May; 57(2):158-64. PubMed ID: 7729727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of adenocarcinoma in situ of the uterine cervix: a comparison of loop electrosurgical excision procedure and cold knife conization.
    Latif NA; Neubauer NL; Helenowski IB; Lurain JR
    J Low Genit Tract Dis; 2015 Apr; 19(2):97-102. PubMed ID: 25089550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma in situ of the uterine cervix: management and outcome.
    Widrich T; Kennedy AW; Myers TM; Hart WR; Wirth S
    Gynecol Oncol; 1996 Jun; 61(3):304-8. PubMed ID: 8641606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases.
    Ostör AG; Duncan A; Quinn M; Rome R
    Gynecol Oncol; 2000 Nov; 79(2):207-10. PubMed ID: 11063645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk for residual adenocarcinoma in situ or cervical adenocarcinoma in women undergoing loop electrosurgical excision procedure/conization for adenocarcinoma in situ.
    DeSimone CP; Day ME; Dietrich CS; Tovar MM; Modesitt SC
    J Reprod Med; 2011; 56(9-10):376-80. PubMed ID: 22010519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of cold knife cone biopsy and loop electrosurgical excision procedure in the management of cervical adenocarcinoma in situ: What is the gold standard?
    Munro A; Leung Y; Spilsbury K; Stewart CJ; Semmens J; Codde J; Williams V; O'Leary P; Steel N; Cohen P
    Gynecol Oncol; 2015 May; 137(2):258-63. PubMed ID: 25769659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective management of stage IA(1) cervical adenocarcinoma by conization alone to preserve fertility: a preliminary report.
    Schorge JO; Lee KR; Sheets EE
    Gynecol Oncol; 2000 Aug; 78(2):217-20. PubMed ID: 10926806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Cold-Knife Conization versus Loop Electrosurgical Excision for Cervical Adenocarcinoma In Situ (ACIS): A Systematic Review and Meta-Analysis.
    Jiang Y; Chen C; Li L
    PLoS One; 2017; 12(1):e0170587. PubMed ID: 28125627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenocarcinoma in situ of the uterine cervix.
    Muntz HG; Bell DA; Lage JM; Goff BA; Feldman S; Rice LW
    Obstet Gynecol; 1992 Dec; 80(6):935-9. PubMed ID: 1448263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma in situ of the cervix: management and outcome.
    Azodi M; Chambers SK; Rutherford TJ; Kohorn EI; Schwartz PE; Chambers JT
    Gynecol Oncol; 1999 Jun; 73(3):348-53. PubMed ID: 10366458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of negative cone margin status for risk of residual disease among women with cervical adenocarcinoma in situ.
    Kietpeerakool C; Khunamornpong S; Srisomboon J; Kasunan A; Sribanditmongkol N; Siriaungkul S
    Int J Gynaecol Obstet; 2012 Dec; 119(3):266-9. PubMed ID: 22939281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix.
    Denehy TR; Gregori CA; Breen JL
    Obstet Gynecol; 1997 Jul; 90(1):1-6. PubMed ID: 9207802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of adenocarcinoma in situ (ACIS) of the uteri cervix--a clinical dilemma.
    Tay EH; Yew WS; Ho TH
    Singapore Med J; 1999 Jan; 40(1):36-9. PubMed ID: 10361484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is electrosurgical loop excision with negative margins sufficient treatment for cervical ACIS?
    Bryson P; Stulberg R; Shepherd L; McLelland K; Jeffrey J
    Gynecol Oncol; 2004 May; 93(2):465-8. PubMed ID: 15099963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenocarcinoma in situ of the uterine cervix: a metaanalysis of 1278 patients evaluating the predictive value of conization margin status.
    Salani R; Puri I; Bristow RE
    Am J Obstet Gynecol; 2009 Feb; 200(2):182.e1-5. PubMed ID: 19019325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ.
    Kennedy AW; elTabbakh GH; Biscotti CV; Wirth S
    Gynecol Oncol; 1995 Aug; 58(2):274-7. PubMed ID: 7622120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of persistent or recurrent neoplasia in conservatively treated women with cervical adenocarcinoma in situ with negative histological margins.
    Munro A; Codde J; Spilsbury K; Stewart CJ; Steel N; Leung Y; Tan J; Salfinger SG; Mohan GR; Semmens JB; Cohen PA
    Acta Obstet Gynecol Scand; 2017 Apr; 96(4):432-437. PubMed ID: 28181670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.